Literature DB >> 29971733

Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies.

Wutyi S Aung1, Rahul P Bakshi1, Jennifer Breakey1, James E Johnson1, Craig W Hendrix1, Ethel Weld1, Edward J Fuchs1, Mark A Marzinke2,3.   

Abstract

Evaluating the efficacy of any HIV prevention strategy is dependent on ensuring and objectively monitoring adherence to the intervention. Medicated rectal enemas are a potential method for providing topical, episodic HIV prophylaxis during receptive anal intercourse. Assessing adherence to recommended enema dosing regimens is essential in evaluating the utility of this strategy. We utilized fecal coliform bacteria on used enema tips as a marker for enema use. Enema tip coliforms were tested by repurposing a microtiter plate-based water quality test designed to detect fecal contamination of water. Coliform detection occurred with 100% sensitivity and specificity when tips were assayed on day of use. The assay performed well post-7 day sample storage at room temperature, yielding a sensitivity of 80% and specificity of 93%. All (n = 64) samples collected in a subset of the DREAM-01 rectal microbicide enema clinical trial tested positive, even when tips were evaluated > 7 days post-reported use. The coliform-based enema tip assay allows monitoring of adherence in interventions involving rectal enemas in a sensitive, specific and inexpensive manner. The test performs well in clinical trial settings.

Entities:  

Keywords:  Adherence; Enema; PrEP; Topical; Validation

Mesh:

Substances:

Year:  2019        PMID: 29971733      PMCID: PMC6883768          DOI: 10.1007/s10461-018-2211-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  23 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.

Authors:  Peter L Anderson; Albert Y Liu; Jose R Castillo-Mancilla; Edward M Gardner; Sharon M Seifert; Cricket McHugh; Theresa Wagner; Kayla Campbell; Mary Morrow; Mustafa Ibrahim; Susan Buchbinder; Lane R Bushman; Jennifer J Kiser; Samantha MaWhinney
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Authors:  Jeanne M Marrazzo; Gita Ramjee; Barbra A Richardson; Kailazarid Gomez; Nyaradzo Mgodi; Gonasagrie Nair; Thesla Palanee; Clemensia Nakabiito; Ariane van der Straten; Lisa Noguchi; Craig W Hendrix; James Y Dai; Shayhana Ganesh; Baningi Mkhize; Marthinette Taljaard; Urvi M Parikh; Jeanna Piper; Benoît Mâsse; Cynthia Grossman; James Rooney; Jill L Schwartz; Heather Watts; Mark A Marzinke; Sharon L Hillier; Ian M McGowan; Z Mike Chirenje
Journal:  N Engl J Med       Date:  2015-02-05       Impact factor: 91.245

5.  Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.

Authors:  Anke Hemmerling; William G Harrison; Joelle Morgan Brown; Barbara Moscicki; Maria Oziemkowska; Elizabeth A Bukusi; Craig R Cohen
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

6.  Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).

Authors:  Craig W Hendrix; Adriana Andrade; Namandjé N Bumpus; Angela D Kashuba; Mark A Marzinke; Ayana Moore; Peter L Anderson; Lane R Bushman; Edward J Fuchs; Ilene Wiggins; Christine Radebaugh; Heather A Prince; Rahul P Bakshi; Ruili Wang; Paul Richardson; Eugenie Shieh; Laura McKinstry; Xin Li; Deborah Donnell; Vanessa Elharrar; Kenneth H Mayer; Kristine B Patterson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-10-15       Impact factor: 2.205

7.  "White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients.

Authors:  Thomas J Podsadecki; Bernard C Vrijens; Eric P Tousset; Richard A Rode; George J Hanna
Journal:  HIV Clin Trials       Date:  2008 Jul-Aug

8.  Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.

Authors:  K Rivet Amico; Michael J Stirratt
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

9.  Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

Authors:  Ariane van der Straten; Elizabeth R Brown; Jeanne M Marrazzo; Michael Z Chirenje; Karen Liu; Kailazarid Gomez; Mark A Marzinke; Jeanna M Piper; Craig W Hendrix
Journal:  J Int AIDS Soc       Date:  2016-02-04       Impact factor: 5.396

Review 10.  Microbicide clinical trial adherence: insights for introduction.

Authors:  Cynthia Woodsong; Kathleen MacQueen; K Rivet Amico; Barbara Friedland; Mitzy Gafos; Leila Mansoor; Elizabether Tolley; Sheena McCormack
Journal:  J Int AIDS Soc       Date:  2013-04-08       Impact factor: 5.396

View more
  1 in total

1.  Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).

Authors:  Albert Y Liu; Aliza Norwood; Holly Gundacker; Alex Carballo-Diéguez; Sherri Johnson; Karen Patterson; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Kenneth H Mayer; Carmen Zorrilla; Susan Buchbinder; Jeanna M Piper; Javier R Lama; Ross D Cranston
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.